Live Breaking News & Updates on Therapeutic Advances|Page 9
Stay updated with breaking news from Therapeutic advances. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Experts discuss the necessity of ESR1 mutation testing when considering treatment with elacestrant in patients with estrogen receptor–positive (ER+)/HER2-negative (HER2–) metastatic breast cancer and discuss unmet needs in this patient population. They also describe options for mutation and resistance marker testing to guide treatment selection. ....
COVID-19 shot study shows mo' myocarditis, mo' myocarditis, mo' myocarditis washingtontimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from washingtontimes.com Daily Mail and Mail on Sunday newspapers.
The U.S. government, the mainstream media, and so-called experts long downplayed the possibility of a link between heart inflammation and COVID-19 vaccines. Elements of the medical establishment and social media companies worked to shut up those who dared to press the issue. Health officials a. ....
Experts discuss how they determine whether a patient with metastatic breast cancer is a candidate for treatment with elacestrant based on FDA approved indication, NCCN guidelines, and the results of ESR1 mutation and resistance marker testing. Participants also discuss how they determine treatment failure or resistance. ....